Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Novyra Pharmachem Ltd (NSE: NOVYRA), ISIN INE856E01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NOVYRA last traded at ₹8.50, with a 52-week range of ₹6.79 to ₹16.55 (as of 29 Sep 2026).
Shareholding as of Dec 2025: promoters 23.15%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.